Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 1, 2009, Pages

  Adegoke, Olasunkanmi A J ^a,b   Chevalier, Stéphanie ^b,c   Morais, José A ^b,c   Gougeon, Réjeanne ^b,c   Kimball, Scot R ^d   Jefferson, Leonard S ^d   Wing, Simon S ^b,c   Marliss, Errol B ^c  

^a YORK UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose turnover; Insulin resistance; Leucine kinetics; Translation initiation; Ubiquitin pathway

Indexed keywords

ATROGIN 1; CARBON 13; GLUCOSE; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B; S6 KINASE; TRITIUM; UBIQUITIN;

AMINOACIDEMIA; ARTICLE; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; MALE; MUSCLE BIOPSY; MUSCLE CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UBIQUITINATION; VASTUS LATERALIS MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AMINO ACIDS; BIOPSY; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; LEUCINE; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHOPROTEINS; POSTPRANDIAL PERIOD; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES; RNA, MESSENGER; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 58249112390     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90752.2008     Document Type: Article

References (50)

1. Abumrad NN, Robinson RP, Gooch BR, Lacy WW. The effect of leucine infusion on substrate flux across the human forearm. J Surg Res 32: 453-463, 1982.
2. Adegoke OAJ, Chevalier S, Labib N, Lamarche M, Gougeon R, Morais JA, Kimball SR, Jefferson LS, Wing SS, Marliss EB. Whole-body protein turnover and molecular mechanisms regulating human skeletal muscle protein metabolism in the fed state (Abstract). Diabetes 55, Suppl 1: A289, 2006.
3. Anthony JC, Reiter AK, Anthony TG, Crozier SJ, Lang CH, MacLean DA, Kimball SR, Jefferson LS. Orally administered leucine enhances protein synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-BP1 or S6K1 phosphorylation. Diabetes 51: 928-936, 2002.
4. Bolster DR, Vary TC, Kimball SR, Jefferson LS. Leucine regulates translation initiation in rat skeletal muscle via enhanced eIF4G phosphorylation. J Nutr 134: 1704-1710, 2004.
5. Bradley DC, Steil GM, Bergman RN. Quantitation of measurement error with Optimal Segments: basis for adaptive time course smoothing. Am J Physiol Endocrinol Metab 264: E902-E911, 1993.
6. Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 80: 1784-1793, 1987.
7. Chevalier S, Gougeon R, Choong N, Lamarche M, Morais JA. Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging. J Gerontol A Biol Sci Med Sci 61: 156 -164, 2006.
8. Chevalier S, Gougeon R, Kreisman SH, Cassis C, Morais JA. The hyperinsulinemic amino acid clamp increases whole-body protein synthesis in young subjects. Metabolism 53: 388-396, 2004.
9. Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R. The influence of sex on the protein anabolic response to insulin. Metabolism 54: 1529-1535, 2005.
10. Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82: 355-365, 2005.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
12. Combaret L, Adegoke OA, Bedard N, Baracos V, Attaix D, Wing SS. USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states. Am J Physiol Endocrinol Metab 288: E693-E700, 2005.
13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantcifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
14. Ferrannini E, Bevilacqua S, Lanzone L, Bonadonna R, Brandi L, Oleggini M, Boni C, Buzzigoli G, Ciociaro D, Luzi L, DeFronzo RA. Metabolic interactions of amino acids and glucose in healthy humans. Diabetes Nutr Metab 3: 175-186, 1988.
15. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924, 1987.
16. Goran MI, Khaled MA. Cross-validation of fat-free mass estimated from body density against bioelectrical resistance: effects of obesity and gender. Obes Res 3: 531-539, 1995.
17. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31: 128-133, 2008.
18. Gougeon R, Pencharz PB, Sigal RJ. Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso- and hypoenergetic feeding. Am J Clin Nutr 65: 861-870, 1997.
19. Gougeon R, Styhler K, Morais JA, Jones PJ, Marliss EB. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 23: 1-8, 2000.
20. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28: 730-738, 2007.
21. Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 4: 183-190, 2001.
22. Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr 136: 227S-231S, 2006.
23. Kimball SR, Jurasinski CV, Lawrence JC Jr, Jefferson LS. Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. Am J Physiol Cell Physiol 272: C754-C759, 1997.
24. Kimball SR, Shantz LM, Horetsky RL, Jefferson LS. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem 274: 11647-11652, 1999.
25. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 65: 1272-1284, 1980.
26. Kolterman OG, Scarlett JA, Olefsky JM. Insulin resistance in non-insulin-dependent, type II diabetes mellitus. Clin Endocrinol Metab 11: 363-388, 1982.
27. Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyer-speer M, Nowotny P, Roth E, Waldhausl W, Roden M. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51: 599 -605, 2002.
28. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39 -51, 2004.
29. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227S-237S, 1999.
30. 2 in human bicarbonate studies: a critical review with original data. Clin Sci (Lond) 91: 665-677, 1996.
31. Luzi L, Petrides AS, De Fronzo RA. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 42: 1868 -1877, 1993.
32. Mandarino LJ, Consoli A, Jain A, Kelley DE. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol Endocrinol Metab 270: E463-E470, 1996.
33. 13C]leucine. Am J Physiol Endocrinol Metab 238: E473-E479, 1980.
34. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996.
35. Mothe-Satney I, Gautier N, Hinault C, Lawrence JC Jr, Van Obberghen E. In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids. J Biol Chem 279: 42628 -42637, 2004.
36. Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR. Bidirectional modulation of insulin action by amino acids. J Clin Invest 101: 1519 -1529, 1998.
37. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57: 56 -63, 2008.
38. Petrides AS, Luzi L, Reuben A, Riely C, DeFronzo RA. Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis. Hepatology 14: 432-441, 1991.
39. Rennie MJ, Bohe J, Smith K, Wackerhage H, Greenhaff P. Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr 136: 264S-268S, 2006.
40. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
41. Schricker T, Meterissian S, Latterman R, Marliss EB, Adegoke OAJ, Mazza L, Eberhart L, Carli F, Nitschman E, Wykes LJ. Avoidance of preoperative fasting by intravenous hypocaloric nutrition reduces whole body protein catabolism and stimulates albumin synthesis after surgery. Ann Surg. In press.
42. Schwenk WF, Haymond MW. Decreased uptake of glucose by human forearm during infusion of leucine, isoleucine, or threonine. Diabetes 36: 199-204, 1987.
43. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
44. Tessari P, Inchiostro S, Biolo G, Duner E, Nosadini R, Tiengo A, Crepaldi G. Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. Diabetologia 28: 870-872, 1985.
45. Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, Duner E, Biolo G, Marescotti MC, Tiengo A, Crepaldi G. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. J Clin Invest 77: 1797-1804, 1986.
46. Tessari P, Trevisan R, Inchiostro S, Biolo G, Nosadini R, De Kreutzenberg SV, Duner E, Tiengo A, Crepaldi G. Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol Endocrinol Metab 251: E334-E342, 1986.
47. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhausl W, Marette A, Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54: 2674-2684, 2005.
48. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 307: 639-645, 1995.
49. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss, 1992, p. 388.
50. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 124: 471-484, 2006.